Dave Scott of Tepnal Pharma Services discusses the success of the life sciences industry and how the Scotsman conference can contribute to this. To date, 2018 has been another great year for our Life Sciences community. Across the spectrum of different disciplines that make up Life Sciences in Scotland, both pure science and applied science companies continue to compete and win on a global platform. The...
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces it has signed distribution agreements with two new Chinese channel partners, Dakewe Biotech Co., Ltd and Shanghai Regenic Biomedical. The appointment of these channel partners follows the restructuring of the Company’s presence in China and the securing of export licences earlier this year. This is...
Heart attack survivors are benefiting from a pioneering therapy involving stem cells harvested from their own blood. A pilot study involving seven patients found the treatment can repair heart tissue damaged after the initial attack. Normal function Ten years after their treatment, six out of seven patients had near normal heart function. Before the study, three of them had such severe heart failure they were...
The £4 million project seeks to better understand the environment in which stem cells grow in the body, known as the niche. Experts will use their findings to design new therapies that mimic this environment, in order to stimulate repair mechanisms in tissues damaged by disease or injury. Researchers at the University of Edinburgh are leading the collaboration, called the UK Regenerative Medicine Platform (UKRMP)-Engineered...
RoslinCT, a UK-based cell and gene therapy contract manufacturing organisation, is delighted to be part of the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) consortium. As an industry partner within the consortium, RoslinCT will provide advice on the development, manufacture and clinical supply of cell, gene and tissue engineered therapies. Unlike most conventional medicinal products, advanced therapies offer the potential to cure many degenerative diseases...
In a bid to save £200,000 a year, Scottish life sciences firm Collagen Solutions is planning to move some of its manufacturing from New Zealand to Glasgow. The Glasgow-based firm, which specialises in medical grade collagen and tissue components, said it is looking at a restructuring of its business in New Zealand to focus on tissue collection and processing. Chief executive Jamal Rushdy, said: “ There are two...